Search Results - "Monteiro FSM"

An agent-based learning model integrating sex differences in renal cell carcinoma.

Authors: Merelli E Taha T Caputo M et al.

Source: Frontiers in immunology [Front Immunol] 2026 Apr 01; Vol. 17, pp. 1779638. Date of Electronic Publication: 2026 Apr 01 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV).

Authors: Mollica V Massari F Fujita K et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Mar 24; Vol. 75 (4). Date of Electronic Publication: 2026 Mar 24.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario?

Authors: Cerbone L Roviello G Calabrò F et al.

Source: Frontiers in immunology [Front Immunol] 2026 Feb 24; Vol. 17, pp. 1667155. Date of Electronic Publication: 2026 Feb 24 (Print Publication: 2026).

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working group.

Authors: Calabrò C Ciccimarra F Rizzo A et al.

Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2026 Jan; Vol. 27 (1), pp. 27-37. Date of Electronic Publication: 2026 Feb 06.

Publication Type: Review; Journal Article

Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE

Infusion-Related Reactions Among Cancer Patients Receiving Immune Checkpoint Inhibitors: The ARON-MOUSEION-013 Systematic Review and Meta-Analysis.

Authors: Vitale E Rizzo A Maistrello L et al.

Source: Drug design, development and therapy [Drug Des Devel Ther] 2025 Dec 13; Vol. 19, pp. 11107-11118. Date of Electronic Publication: 2025 Dec 13 (Print Publication: 2025).

Publication Type: Journal Article; Meta-Analysis; Systematic Review

Journal Info: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE

Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study.

Authors: Kopp RM Massari F Grande E et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Nov 14; Vol. 74 (12), pp. 374. Date of Electronic Publication: 2025 Nov 14.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Prostate Cancer Treatment Patterns and Inequities Among Racial Groups in Brazil's Public Health System: Insights From a 16-Year Real-World Study.

Authors: Herchenhorn D Abboud H Freire V et al.

Source: JCO global oncology [JCO Glob Oncol] 2026 May; Vol. 12 (5), pp. e2500712. Date of Electronic Publication: 2026 May 29.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101760170 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2687-8941 (Electronic) Linking ISSN: 26878941 NLM ISO Abbreviation: JCO Glob Oncol Subsets: MEDLINE

Reply to: Comments on "Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)".

Authors: Molina-Cerrillo J Roviello G Fiala O et al.

Source: International journal of cancer [Int J Cancer] 2026 Apr 01; Vol. 158 (7), pp. 1992-1994. Date of Electronic Publication: 2025 Dec 16.

Publication Type: Letter

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE; In Process

Re: Fernando Cotait Maluf, Karine Trindade, Daniel Preto, et al. Pembrolizumab plus Platinum-based Chemotherapy for Patients with Advanced Penile Cancer: The Nonrandomized HERCULES (LACOG 0218) Clinical Trial. JAMA Oncol. In press. https://doi.org/10.1001/jamaoncol.2025.3266.

Authors: Monteiro FSM Santoni M Spiess PE

Source: European urology [Eur Urol] 2026 Apr; Vol. 89 (4), pp. e101-e102. Date of Electronic Publication: 2025 Nov 14.

Publication Type: Letter

Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE; In Process

Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study.

Authors: Porta C Massari F Taha T et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 May 09; Vol. 74 (7), pp. 196. Date of Electronic Publication: 2025 May 09.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Efficacy and safety of immune-based combinations in metastatic hepatocellular carcinoma: a systematic review and network meta-analysis.

Authors: de Moura ACC Rizzo A Santos TAB et al.

Source: BMC cancer [BMC Cancer] 2026 Mar 25; Vol. 26 (1). Date of Electronic Publication: 2026 Mar 25.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE; In Process

Hyponatremia in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-014 meta-analysis.

Authors: Vitale E Maistrello L Ciccimarra F et al.

Source: Cancer metastasis reviews [Cancer Metastasis Rev] 2026 Mar 17; Vol. 45 (2). Date of Electronic Publication: 2026 Mar 17.

Publication Type: Journal Article; Meta-Analysis; Systematic Review; Review

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8605731 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7233 (Electronic) Linking ISSN: 01677659 NLM ISO Abbreviation: Cancer Metastasis Rev Subsets: MEDLINE

Optimizing the Systemic Treatment for Metastatic Castration-Resistant Prostate Cancer in Lower-Middle-Income Countries: A 7-Year Analysis of the Brazilian Public Health System.

Authors: Monteiro FSM Souza VC da Trindade KM et al.

Source: JCO global oncology [JCO Glob Oncol] 2026 Mar; Vol. 12 (3), pp. e2500683. Date of Electronic Publication: 2026 Mar 31.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101760170 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2687-8941 (Electronic) Linking ISSN: 26878941 NLM ISO Abbreviation: JCO Glob Oncol Subsets: MEDLINE

Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study).

Authors: Molina-Cerrillo J Roviello G Bourlon MT et al.

Source: International journal of cancer [Int J Cancer] 2026 Mar 01; Vol. 158 (5), pp. 1396-1405. Date of Electronic Publication: 2025 Nov 04.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2^EV study.

Authors: Fiala O Buti S Fujita K et al.

Source: Clinical & experimental metastasis [Clin Exp Metastasis] 2025 Feb 20; Vol. 42 (2), pp. 18. Date of Electronic Publication: 2025 Feb 20.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE

Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study.

Authors: Monteiro FSM Alencar Junior AM da Trindade KM et al.

Source: The oncologist [Oncologist] 2025 Feb 06; Vol. 30 (2).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study.

Authors: Roviello G Molina-Cerrillo J Massari F et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Jan 03; Vol. 74 (2), pp. 65. Date of Electronic Publication: 2025 Jan 03.

Publication Type: Journal Article; Multicenter Study; Comparative Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study.

Authors: Rizzo A Monteiro FSM Mollica V et al.

Source: Clinical & experimental metastasis [Clin Exp Metastasis] 2024 Dec 30; Vol. 42 (1), pp. 9. Date of Electronic Publication: 2024 Dec 30.

Publication Type: Journal Article; Meta-Analysis; Systematic Review

Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE

Impact of time-of-day administration of immunotherapy on survival in metastatic renal cell carcinoma: the MOUSEION-09 meta-analysis.

Authors: Rizzo A Monteiro FSM Mollica V et al.

Source: Clinical & experimental metastasis [Clin Exp Metastasis] 2024 Dec 16; Vol. 42 (1), pp. 3. Date of Electronic Publication: 2024 Dec 16.

Publication Type: Journal Article; Meta-Analysis; Systematic Review

Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE

Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de-differentiation (ARON-1 study).

Authors: Ciccarese C Büttner T Cerbone L et al.

Source: International journal of cancer [Int J Cancer] 2024 Dec 01; Vol. 155 (11), pp. 2036-2046. Date of Electronic Publication: 2024 Sep 07.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE